Pall Biotech

Key Considerations for Downstream Manufacturing Commercialization of Gene Therapy Vectors


Inspired by incredible clinical results, recent FDA gene therapy approvals, and the promise of more gene therapies to come, the Cell Culture Dish partnered with Fujifilm, WuXi App Tec, Adverum Biotechnologies and Pall Biotech, to create this educational article, 'Downstream Manufacturing of Gene Therapy Vectors'.

The article adressses:
  • Downstream processing challenges and scale-up
  • Cost considerations in downstream manufacturing
  • How to reduce time to market

Fill out the Form
to Download the Article

* All fields required